We are live on ! Find out more
AMPE

Ampio Pharmaceuticals Inc.
AMPE

Delisted

AMPE was delisted on the 12th of April, 2024.

Back to rankings

79 hedge funds and large institutions have $11.2M invested in Ampio Pharmaceuticals Inc. in 2020 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 12 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more call options, than puts

Call options by funds: $380K | Put options by funds: $95K

75% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 12

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

62% more capital invested

Capital invested by funds: $6.92M → $11.2M (+$4.32M)

3% more funds holding

Funds holding: 77 → 79 (+2)

Holders
79
Holders Change
+2
Holders Change %
+2.6%
% of All Funds
1.62%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
21
Reduced
12
Closed
6
Calls
$380K
Puts
$95K
Net Calls
+$285K
Net Calls Change
+$117K

Top Buyers

Rank Fund Capital Flow
1
BCM
Bridgeway Capital Management
Texas
+$649K
2
PCMC
Private Capital Management (Colorado)
Colorado
+$308K
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$200K
4
BlackRock
BlackRock
New York
+$186K
5
Wells Fargo
Wells Fargo
California
+$98.1K

Top Sellers

Rank Fund Capital Flow
1
AAP
Arax Advisory Partners
Colorado
-$639K
2
HC
HNP Capital
New York
-$200K
3
Citadel Advisors
Citadel Advisors
Florida
-$86K
4
Osaic Holdings
Osaic Holdings
Arizona
-$42.4K
5
WS
Wedbush Securities
California
-$21.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
JWM
51
Janiczek Wealth Management
Colorado
$11K – – –
SS
52
Sunbelt Securities
Texas
$10K +$1.66K +10 +25%
BSW
53
Buckingham Strategic Wealth
Missouri
$10K +$8.98K +54 New
PNC Financial Services Group
54
PNC Financial Services Group
Pennsylvania
$9K – – –
BCM
55
Brookstone Capital Management
Illinois
$8K – – –
Royal Bank of Canada
56
Royal Bank of Canada
Ontario, Canada
$8K +$6.15K +37 +740%
CHA
57
Cooper/Haims Advisors
New York
$8K +$7.15K +43 New
Citigroup
58
Citigroup
New York
$7K – – –
PAG
59
Private Advisor Group
New Jersey
$7K +$5.82K +35 New
CAL
60
Capital Analysts LLC
Pennsylvania
$6K – – –
OC
61
Oppenheimer & Co
New York
$6K – – –
WA
62
WealthTrust Axiom
Pennsylvania
$6K – – –
Northwestern Mutual Wealth Management
63
Northwestern Mutual Wealth Management
Wisconsin
$5K – – –
Bank of America
64
Bank of America
North Carolina
$3K – – –
SCA
65
Stonebridge Capital Advisors
Minnesota
$3K – – –
TRCT
66
Tower Research Capital (TRC)
New York
$3K +$333 +2 +17%
CCM
67
Covington Capital Management
California
$2K – – –
CAN
68
Cetera Advisor Networks
California
$2K +$1.33K +8 New
AWM
69
Apollon Wealth Management
South Carolina
$2K +$1.83K +11 New
AF
70
Allworth Financial
California
$1K – – –
CAGAS
71
Capital Advisory Group Advisory Services
Minnesota
$1K – – –
CFG
72
Citizens Financial Group
Rhode Island
$1K – – –
CTB
73
Country Trust Bank
Illinois
$1K – – –
MA
74
MUFG Americas
New York
$1K – – –
UBS Group
75
UBS Group
Switzerland
$1K – – –
1 2
3
4

AMPE Hedge Fund Activity: Q2 2020 in Review

79 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2020, worth a combined $11.2M — up 62% from $6.92M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new AMPE positions and 6 closed out — a net gain of 4 holders — while 21 added to existing stakes and 12 trimmed.

The largest buyer was Bridgeway Capital Management, opening a new position worth an estimated $649K. The largest seller was Arax Advisory Partners, cutting an estimated $639K.

  • 79 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2020, up from 77 in Q1 2020.
  • Funds reported $11.2M of Ampio Pharmaceuticals Inc. stock for Q2 2020, up 62% quarter-over-quarter.
  • 10 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2020 and 6 closed out, a net change of +4 holders.
  • The largest Ampio Pharmaceuticals Inc. buyer in Q2 2020 was Bridgeway Capital Management, an estimated $649K added.
  • The largest Ampio Pharmaceuticals Inc. seller in Q2 2020 was Arax Advisory Partners, an estimated $639K sold.

Based on aggregated 13F filings for Q2 2020.